Christos Coutifaris
Direktor/Vorstandsmitglied bei American Society for Reproductive Medicine
Aktive Positionen von Christos Coutifaris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Christos Coutifaris
Ehemalige bekannte Positionen von Christos Coutifaris
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Commercial Services |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
- Börse
- Insiders
- Christos Coutifaris
- Erfahrung